Tara Lynn Kieffer

Insider Reports History

Entity
Individual
Location
C/O Enanta Pharmaceuticals, Inc., 500 Arsenal Street, Watertown, MA
Signature
/s/ Matthew Kowalsky as attorney-in-fact
All insider transactions
Transactions in reports broken out by “transaction date” reported in original SEC filing, see here for transactions aggregated across transaction date

Holdings reported by Tara Lynn Kieffer:

Stock Role Class Num Shares Value Price $ Report Date Ownership
ENANTA PHARMACEUTICALS INC Chief Product Strategy Officer Common Stock 29.3K $236K $8.06 Dec 6, 2024 Direct
ENANTA PHARMACEUTICALS INC Chief Product Strategy Officer Stock Option (right to buy) 81K Nov 27, 2024 Direct

Insider Reports Filed by Tara Lynn Kieffer

Symbol Company Period Transactions Value $ Form Type Date Filed Role
ENTA ENANTA PHARMACEUTICALS INC Dec 6, 2024 1 -$18.4K 4 Dec 10, 2024 Chief Product Strategy Officer
ENTA ENANTA PHARMACEUTICALS INC Dec 1, 2024 1 -$6.48K 4 Dec 3, 2024 Chief Product Strategy Officer
ENTA ENANTA PHARMACEUTICALS INC Nov 27, 2024 1 $0 4 Nov 27, 2024 Chief Product Strategy Officer
ENTA ENANTA PHARMACEUTICALS INC Jun 17, 2024 1 -$89.6K 4 Jun 17, 2024 Chief Product Strategy Officer
ENTA ENANTA PHARMACEUTICALS INC Feb 12, 2024 2 -$12.1K 4 Feb 14, 2024 Chief Product Strategy Officer
ENTA ENANTA PHARMACEUTICALS INC Dec 5, 2023 1 -$20.5K 4 Dec 6, 2023 Sr. VP, New Prod. Strat. & Dev
ENTA ENANTA PHARMACEUTICALS INC Dec 1, 2023 1 -$7.15K 4 Dec 5, 2023 Sr. VP, New Prod. Strat. & Dev
ENTA ENANTA PHARMACEUTICALS INC Nov 22, 2023 1 $0 4 Nov 22, 2023 Sr. VP, New Prod. Strat. & Dev
ENTA ENANTA PHARMACEUTICALS INC Feb 13, 2023 3 -$355K 4 Feb 15, 2023 Sr. VP, New Product Dev.
ENTA ENANTA PHARMACEUTICALS INC Dec 1, 2022 1 -$22.1K 4 Dec 5, 2022 Sr. VP, New Product Dev.
ENTA ENANTA PHARMACEUTICALS INC Nov 23, 2022 2 $0 4 Nov 28, 2022 Sr. VP, New Product Dev.
ENTA ENANTA PHARMACEUTICALS INC Feb 14, 2022 3 -$34.5K 4 Feb 15, 2022 Sr. VP, New Product Dev.
ENTA ENANTA PHARMACEUTICALS INC Nov 19, 2021 2 $0 4 Nov 23, 2021 Sr. VP, New Product Dev.